MUSTANG BIO, INC. Diluted Shares Outstanding (Weighted Average)
MUSTANG BIO, INC. (MBIO) reported Diluted Shares Outstanding (Weighted Average) of 6.73 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-05
- MUSTANG BIO, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 6.73M shares, a 67.43% increase year-over-year.
- MUSTANG BIO, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 6.73M shares, a 135.23% increase year-over-year.
- MUSTANG BIO, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 6.47M shares, a 510.98% increase year-over-year.
- MUSTANG BIO, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 6.24M shares, a 765.80% increase year-over-year.
- MUSTANG BIO, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 4.91M shares, a 705.02% increase from fiscal 2024.
- MUSTANG BIO, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 609.70K shares, a 254.41% increase from fiscal 2023.
- MUSTANG BIO, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 172.03K shares, a 97.76% decline from fiscal 2022.
- MUSTANG BIO, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 7.68M shares, a 91.26% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 6.73M shares 10-Q · filed 2026-08-05 | 6.73M shares 10-Q · filed 2026-08-05 | 6.64M shares derived: average of 3 quarters · filed 2026-08-05 | 6.54M shares derived: average of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | 6.73M shares 10-Q · filed 2026-05-05 | 6.60M shares derived: average of 2 quarters · filed 2026-05-05 | 6.48M shares derived: average of 3 quarters · filed 2026-05-05 | 5.87M shares derived: average of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | 6.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 6.36M shares derived: average of 2 quarters · filed 2026-03-19 | 5.58M shares derived: average of 3 quarters · filed 2026-08-05 | 4.91M shares 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | 6.24M shares 10-Q · filed 2025-11-07 | 5.13M shares derived: average of 2 quarters · filed 2026-08-05 | 4.39M shares 10-Q · filed 2025-11-07 | 3.55M shares derived: average of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | 4.02M shares 10-Q · filed 2026-08-05 | 3.44M shares 10-Q · filed 2026-08-05 | 2.65M shares derived: average of 3 quarters · filed 2026-08-05 | 2.17M shares derived: average of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | 2.86M shares 10-Q · filed 2026-05-05 | 1.96M shares derived: average of 2 quarters · filed 2026-05-05 | 1.55M shares derived: average of 3 quarters · filed 2026-05-05 | 1.27M shares derived: average of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | 1.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 890.06K shares derived: average of 2 quarters · filed 2026-03-19 | 742.24K shares derived: average of 3 quarters · filed 2026-03-19 | 609.70K shares 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | 720.91K shares 10-Q · filed 2025-11-07 | 36.84M shares 10-Q · filed 2024-11-08 | 583.75K shares derived: average of 2 quarters · filed 2025-11-07 | 459.86K shares 10-Q · filed 2025-11-07 | 23.79M shares 10-Q · filed 2024-11-08 | -5.58M shares derived: average of 4 quarters · filed 2025-11-07 | ||
| 2024-06-30 | 446.59K shares 10-Q · filed 2025-08-08 | 23.12M shares 10-Q · filed 2024-08-13 | 327.89K shares 10-Q · filed 2025-08-08 | 17.09M shares 10-Q · filed 2024-08-13 | -7.68M shares derived: average of 3 quarters · filed 2025-08-08 | -3.72M shares derived: average of 4 quarters · filed 2025-08-08 | ||
| 2024-03-31 | 209.20K shares 10-Q · filed 2025-05-14 | 11.25M shares 10-Q · filed 2024-05-15 | -11.75M shares derived: average of 2 quarters · filed 2025-05-14 | -5.11M shares derived: average of 3 quarters · filed 2025-05-14 | -1.80M shares derived: average of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -23.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -7.77M shares derived: average of 2 quarters · filed 2025-03-28 | -2.47M shares derived: average of 3 quarters · filed 2025-03-28 | 172.03K shares 10-K · filed 2025-03-28 | 8.60M shares 10-K · filed 2024-03-11 | |||
| 2023-09-30 | 8.17M shares 10-Q · filed 2024-11-08 | 8.15M shares derived: average of 2 quarters · filed 2024-11-08 | 8.13M shares 10-Q · filed 2024-11-08 | 8.08M shares derived: average of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | 8.13M shares 10-Q · filed 2024-08-13 | 8.11M shares 10-Q · filed 2024-08-13 | 8.04M shares derived: average of 3 quarters · filed 2024-08-13 | 8.00M shares derived: average of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | 8.09M shares 10-Q · filed 2024-05-15 | 8.00M shares derived: average of 2 quarters · filed 2024-05-15 | 7.95M shares derived: average of 3 quarters · filed 2024-05-15 | 7.88M shares derived: average of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | 7.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | 7.88M shares derived: average of 2 quarters · filed 2024-03-11 | 7.81M shares derived: average of 3 quarters · filed 2024-03-11 | 7.68M shares 10-K · filed 2024-03-11 | 103.43M shares 10-K · filed 2023-03-30 | |||
| 2022-09-30 | 7.85M shares 10-Q · filed 2023-11-14 | 105.92M shares 10-Q · filed 2022-11-14 | 7.75M shares derived: average of 2 quarters · filed 2023-11-14 | 7.61M shares 10-Q · filed 2023-11-14 | 102.29M shares 10-Q · filed 2022-11-14 | 28.72M shares derived: average of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | 7.65M shares 10-Q · filed 2023-08-14 | 102.95M shares 10-Q · filed 2022-08-11 | 7.49M shares 10-Q · filed 2023-08-14 | 100.44M shares 10-Q · filed 2022-08-11 | 35.68M shares derived: average of 3 quarters · filed 2023-08-14 | 49.55M shares derived: average of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | 7.32M shares 10-Q · filed 2023-05-12 | 94.07M shares 10-Q · filed 2022-05-12 | 49.70M shares derived: average of 2 quarters · filed 2023-05-12 | 63.51M shares derived: average of 3 quarters · filed 2023-05-12 | 69.52M shares derived: average of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | 92.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 91.61M shares derived: average of 2 quarters · filed 2023-03-30 | 90.26M shares derived: average of 3 quarters · filed 2023-03-30 | 87.89M shares 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 91.14M shares 10-Q · filed 2022-11-14 | 89.35M shares derived: average of 2 quarters · filed 2022-11-14 | 86.49M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 87.56M shares 10-Q · filed 2022-08-11 | 84.03M shares 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | 80.47M shares 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |